The "Precision Pathology" Surge: Is 2026 the Year the Microscope Goes Obsolete?
A major shift in the 2026 global industry is the record-breaking transition to "Digital Pathology 2.0." This year, to cater to the explosion in personalized medicine, the AI in Medical Diagnostics Market has seen its Software segment capture over 55% of revenue. This level of "Molecular Clarity" is the new gold standard, where AI can "see" cellular patterns in a biopsy that are completely...
0 Comments 0 Shares 75 Views 0 Reviews